ArticleJAAD international2024

Real-world outcomes in patients with malignancy and moderate-to-severe psoriasis treated with guselkumab.

Tamara Gracia Cazaña et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.